Palladium-catalyzed Sonogashira cross-coupling reactions of halopurines 9-benzyl-6-chloropurine (2 a), 9-benzyl-8-bromoadenine (2 b), and 9-benzyl-2-chloroadenine (2 c) with ethynylferrocene (1) gave the corresponding (ferrocenylethynyl)purines 3 a-c in moderate to good yields. Catalytic hydrogenation of these alkynes over Pd/C afforded the respective saturated [2-(ferrocenyl)ethyl]purines 4 a-c. The crystal structures 3 a, 3 b, 4 a and 4 b as determined by X-ray diffraction show interesting solid-state interactions, markedly different for purines 3 a and 4 a on one hand and adenines 3 b and 4 b that possess a free amino group on the other. Electrochemistry of electrochemically labelled purines 3 and 4 has been studied by voltammetry and cyclic voltammetry on platinum disc electrode and the experimental oxidation potentials were confirmed and explained by ionization potentials from theoretical DFT calculations. Several compounds of this series exhibited a considerable cytostatic effect.
No takes yet. Share an insight, caveat, or question.
Hocek et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: